Marzenna Blonska, PhD

Biological Consequences and Therapeutic Implications of Beta-arrestin2 loss in aggressive Lymphomas

The primary and acquired resistance of lymphoma cells to standard chemotherapy continues to pose a serious problem for patients and clinicians. Our proposed study will explore a novel mechanism by which lymphoma cells become resistant to therapeutic intervention.